AI-ECG Tracker vs VX1
AI Verdict
Choose AI-ECG Tracker if…
Choose the AI-ECG Tracker if your primary need is rapid, highly accurate AI-powered auto-analysis and diagnosis of standard 12-lead ECGs for a broad range of cardiac abnormalities. This tool is ideal for emergency medicine or general cardiology settings requiring quick interpretation of common conditions like arrhythmias, myocardial ischemia, and infarction, with comprehensive diagnostic classifications.
View AI-ECG Tracker →Choose VX1 if…
Choose VX1 if you are a cardiac electrophysiologist seeking real-time AI guidance during atrial fibrillation and atrial tachycardia ablation procedures. This specialized software integrates with existing EP lab systems to assist in identifying dispersed electrograms, aiming to reduce inter-operator variability and enhance procedural outcomes.
View VX1 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AI-ECG Tracker | VX1 |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Mobile app, intended for use by qualified healthcare professionals in hospitals and other healthcare facilities. | Software integrated with existing electrophysiology (EP) lab mapping and recording systems. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieBoth tools are designed for ease of use within their specific clinical contexts. AI-ECG Tracker offers a rapid, dedicated diagnostic workflow with both desktop and web interfaces, facilitating quick analysis. VX1 is built for seamless integration into existing electrophysiology lab systems, providing intuitive, real-time guidance during complex ablation procedures without prolonging them.
Clinical Value
VX1While AI-ECG Tracker provides high accuracy for a broad range of ECG diagnoses, VX1 addresses a critical need in a highly specialized and complex interventional procedure (AFib ablation). VX1 has demonstrated in clinical studies its ability to standardize outcomes and improve AF termination rates, with ongoing randomized controlled trials further validating its impact on patient outcomes.
Pricing & Value
TieNeither tool provides publicly available pricing information, making a direct cost comparison impossible. Both offer significant clinical value that could lead to improved patient outcomes and potential cost savings through enhanced efficiency or reduced complications, justifying their investment. Tool B, however, has more explicit mentions of potential cost reduction through improved procedure efficacy and reduced repeat procedures.
Enterprise Readiness
VX1While Tool A benefits from being part of a larger parent company with global reach, Tool B demonstrates strong enterprise readiness through strategic partnerships with major medical technology providers like GE HealthCare for integration into existing EP lab infrastructure. This focus on interoperability and significant funding rounds indicate a robust strategy for broader adoption within health systems.
Innovation
VX1Both tools are innovative, but VX1 stands out as the first FDA-cleared AI tool specifically for real-time assistance during interventional cardiac electrophysiology procedures. Its ability to analyze 3D anatomical maps and guide complex ablation in real-time to standardize outcomes represents a more cutting-edge application of AI in a high-stakes clinical setting.
Support & Docs
VX1While neither tool provides extensive public details on their support infrastructure, Volta Medical explicitly offers a user manual and brochure for VX1 on its website, indicating a commitment to providing documentation. Additionally, Volta Medical has a US office, suggesting local support capabilities.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AI-ECG Tracker | VX1 |
|---|---|---|
| Product Name | AI-ECG Tracker | VX1 |
| Company | Shenzhen Carewell Electronics Co. | Volta Medical |
| Primary Application | AI-powered ECG auto-analysis and diagnosis | AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. |
| Supported Data Type/Input | 12-lead ECG data | Dispersed electrograms (EGMs), 3D anatomical and electrical maps of human atria |
| Key Diagnostic/Assistance Capabilities | AI-powered ECG auto-analysis and diagnosis, high accuracy (over 95%) for common cardiac abnormalities, rapid diagnosis in approximately 3 seconds, comprehensive diagnosis support for 16 cardiac classifications and 104 ECG diagnostic classifications. | AI-guided real-time identification of dispersed electrograms (EGMs), assists cardiologists during AFib and atrial tachycardia ablation procedures, designed to reduce inter-operator variability and standardize outcomes, provides cycle length estimation from electrograms, booster mode for increased sensitivity during AT or slow AF. |
Videos
Demos, reviews, and walkthroughs featuring AI-ECG Tracker and VX1.